![]() |
市場調查報告書
商品編碼
1636784
2030 年合益素產品市場預測:按產品、成分、形式、分銷管道、應用、最終用戶和地區進行的全球分析Synbiotic Products Market Forecasts to 2030 - Global Analysis By Product, Ingredients, Form, Distribution Channel, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球合益素產品市場價值為 6.988 億美元,預計在預測期內將以 9.5% 的複合年成長率成長,到 2030 年將達到 12.046 億美元。
合益素產品是將益生菌(有益的活微生物)和益生元(難消化的食物成分)結合在一起的營養補充劑和機能性食品,可協同增強腸道健康。乳酸菌和雙歧桿菌等益生菌促進腸道菌叢平衡的形成,而源自菊糖和果寡糖等膳食纖維的益生元則為這些微生物提供營養。合益素常見於乳製品、飲料和膠囊中,提供透過最佳化腸道生態系統來維持整體健康的整體方法。
消費者腸道健康意識不斷增強
消費者越來越認知到腸道健康與整體健康之間的聯繫,包括改善消化、增強免疫力和增強心理健康。這種意識正在推動對機能性食品和補充劑的需求,這些食品和補充劑結合了益生菌和益生元(稱為合益素),以支持平衡的腸道菌群。製造商正在創新飲料和零食等有吸引力的產品形式,以滿足不同消費者的喜好。此外,人們對預防性保健的興趣日益濃厚,鼓勵消費者將合益素產品納入日常生活的一部分。社群媒體、健康宣傳活動和營養師的建議進一步放大了這一趨勢,推動了全球市場的擴張。
新興市場缺乏意識
新興市場的消費者通常對合益素產品可提供的健康益處(例如改善消化和增強免疫力)知之甚少。這種缺乏理解減少了需求。這是因為消費者不太可能投資他們不了解或不理解的產品。此外,製造商的教育宣傳活動和行銷力度不足也加劇了這個問題。這些市場的醫療保健專業人員也可能不了解合益素的功效,這進一步限制了他們向消費者的推薦。對傳統治療方法相對於現代保健食品的文化偏好是另一個障礙。因此,合益素市場在這些地區難以獲得牽引力,削弱了全球擴張潛力。
融入多種食物
融入乳製品、飲料、麵包和穀物等多種食品中,製造商能夠滿足尋求機能性食品的注重健康的消費者的需求。這種多功能性使合益素產品能夠無縫地適應不同的飲食偏好和地區美食,從而增加其吸引力。由於方便,強化食品也被忙碌的消費者廣泛採用。此外,食品和生物技術公司之間的合作正在推動合益素配方的創新。因此,合益素市場的需求不斷增加,因為它能夠將健康益處與易於食用和平易近人的食品形式結合。
可能的副作用和消費者的不信任
腹脹、脹氣和過敏等副作用可能會導致使用者不滿意。缺乏有關產品安全性和功效的明確資訊進一步加劇了消費者的懷疑。不一致的監管標準和不足的臨床證據也削弱了對合益素產品的信任。關於副作用的負面評論和口碑使潛在買家望而卻步。此外,由於效果不確定,價格昂貴也阻礙了廣泛使用。教育消費者和提高產品透明度對於克服這些挑戰至關重要。
COVID-19 的影響
COVID-19 大流行對合益素產品市場產生了重大影響。最初,供應鏈中斷和物流挑戰阻礙了生產和分銷。然而,消費者對健康和免疫意識的提高推動了對機能性食品(包括合益素產品)的需求。人們擴大尋求支持腸道健康和增強免疫功能的產品,從而推動該領域的創新和新產品的推出。隨著消費者轉向電子商務平台購買保健品,向線上零售的轉變進一步推動了市場成長。總體而言,雖然疫情帶來了挑戰,但它也為合益素產品市場擴大其覆蓋範圍並順應健康意識趨勢創造了機會。
預計益生菌產業在預測期內將是最大的
由於益生菌對健康的益處有據可查,消費者對腸道健康解決方案的需求不斷成長,預計在預測期內益生菌領域將佔據最大的市場佔有率。作為活的有益細菌,合益素,與益生元結合以增強其功效。由於人們越來越認知到益生菌在改善消化、免疫力和整體健康方面的作用,益生菌在注重健康的消費者中越來越受歡迎。在這個領域,持續的研究和產品創新,包括有針對性的輸送系統和菌株特定的好處,正在推動消費者的信心和採用。此外,消化器官系統和生活方式相關疾病的盛行率不斷上升,進一步推動了對含有益生菌的合益素產品的需求。
兒童產業預計在預測期內複合年成長率最高。
隨著人們越來越認知到腸道健康對整體健康的影響,預計兒童產業在預測期內的複合年成長率最高。父母擴大尋求支持孩子消化器官系統健康和免疫力的機能性食品和飲料。合益素產品結合了益生菌和益生元,透過改善營養吸收和強化腸道微生物群來滿足這項需求。年輕人胃腸道疾病和過敏症的盛行率日益增加,刺激了對此類客製化治療的需求。製造商也正在開發有吸引力的口味和兒童友善的形式,例如軟糖和粉末,以鼓勵消費。這種對兒童的關注符合更廣泛的健康趨勢,推動了這一領域的市場成長。
由於益生菌和益生元組合的優勢,預計亞太地區在預測期內將佔據最大的市場佔有率。健康意識的增強和胃腸道疾病盛行率的增加正在推動對機能性食品和營養補充劑的需求。中國、日本和印度等國家走在前列,擴大了產品系列以針對不同的年齡層。合益素融入乳製品、飲料、嬰兒營養品表現尤為明顯。此外,主要企業的配方創新和研發投入的增加也進一步支持了市場發展。
由於消費者對腸道健康的認知不斷提高以及益生菌和益生元相結合的好處,預計北美在預測期內將表現出最高的複合年成長率。對機能性食品和營養補充劑的需求不斷成長以及對預防保健的關注正在推動市場擴張。該地區強勁的食品和飲料行業以及生物技術的進步進一步推動了產品創新和供應。典型應用包括乳製品、嬰兒奶粉和營養補充品。領先的公司正在投資研發和策略夥伴關係,以跟上不斷變化的消費者偏好,確保這個注重健康的市場的穩定成長。
According to Stratistics MRC, the Global Synbiotic Products Market is accounted for $698.8 million in 2024 and is expected to reach $1204.6 million by 2030 growing at a CAGR of 9.5% during the forecast period. Synbiotic products are dietary supplements or functional foods that combine probiotics (beneficial live microorganisms) and prebiotics (non-digestible food ingredients) to synergistically enhance gut health. Probiotics, such as Lactobacillus or Bifidobacterium strains, promote a balanced gut microbiota, while prebiotics, often derived from fibers like inulin or fructooligosaccharides, serve as nourishment for these microbes. Synbiotics are commonly found in dairy products, beverages, or capsules, offering a holistic approach to maintaining overall health by optimizing the gut's ecosystem.
Rising consumer awareness about gut health
Consumers are increasingly recognizing the connection between gut health and overall well-being, including improved digestion, enhanced immunity, and better mental health. This awareness has fuelled demand for functional foods and supplements that combine probiotics and prebiotics, known as synbiotics, to support a balanced gut microbiome. Manufacturers are innovating with appealing product formats, such as beverages and snacks, to cater to diverse consumer preferences. Additionally, growing interest in preventive healthcare has encouraged consumers to adopt synbiotic products as part of their daily routines. The trend is further amplified by social media, health campaigns, and endorsements by nutritionists, driving market expansion globally.
Lack of awareness in emerging markets
Consumers in these regions often have limited knowledge about the health benefits of synbiotic products, such as improved digestion and immunity. This lack of understanding reduces demand, as individuals are less likely to invest in products they do not recognize or understand. Additionally, insufficient educational campaigns and marketing efforts by manufacturers exacerbate the problem. Healthcare professionals in these markets may also be unaware of synbiotic benefits, further limiting recommendations to consumers. Cultural preferences for traditional remedies over modern health products create an additional barrier. As a result, the market struggles to gain traction in these regions, stalling its global expansion potential.
Integration into diverse food products
Integration into diverse food products like dairy, beverages, bakery, and cereals, manufacturers cater to health-conscious consumers seeking functional foods. This versatility allows synbiotic products to seamlessly align with varying dietary preferences and regional cuisines, enhancing their appeal. The convenience of fortified food options also encourages wider adoption among busy consumers. Additionally, collaborations between food companies and biotech firms are fostering innovation in synbiotic formulations. As a result, the market experiences increased demand due to its ability to blend health benefits with palatable and familiar food formats.
Potential side effects and consumer mistrust
Adverse reactions such as bloating, gas, or allergies can lead to dissatisfaction among users. Lack of clear information about product safety and efficacy further amplifies consumer skepticism. Inconsistent regulatory standards and insufficient clinical evidence also undermine trust in synbiotic products. Negative reviews and word-of-mouth about side effects deter potential buyers. Additionally, high prices for perceived uncertain benefits discourage widespread adoption. Educating consumers and improving product transparency are essential to overcoming these challenges.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the synbiotic products market. Initially, disruptions in supply chains and logistical challenges hindered production and distribution. However, growing consumer awareness about health and immunity boosted demand for functional foods, including synbiotic products. People increasingly sought products that support gut health and enhance immune function, driving innovation and new product launches in the sector. The shift toward online retail further facilitated market growth, as consumers adapted to e-commerce platforms for purchasing health supplements. Overall, while the pandemic presented challenges, it also created opportunities for the synbiotic products market to expand its reach and align with health-conscious trends.
The probiotics segment is expected to be the largest during the forecast period
The probiotics segment is expected to account for the largest market share during the forecast period, due to its well-documented health benefits and growing consumer demand for gut health solutions. Probiotics, as live beneficial bacteria, form a key component of synbiotic formulations, which combine them with prebiotics to enhance their efficacy. Increasing awareness of probiotics' role in improving digestion, immunity, and overall well-being has fuelled their popularity among health-conscious consumers. The segment benefits from ongoing research and product innovations, such as targeted delivery systems and strain-specific benefits, which boost consumer trust and adoption. Additionally, the rising prevalence of digestive disorders and lifestyle-related ailments further drives demand for probiotics-infused synbiotic products.
The children segment is expected to have the highest CAGR during the forecast period
The children segment is anticipated to witness the highest CAGR during the forecast period, due to the growing awareness of gut health's impact on overall well-being. Parents increasingly seek functional foods and beverages to support their children's digestive health and immunity. Synbiotic products, combining probiotics and prebiotics, cater to these demands by improving nutrient absorption and enhancing gut microbiota. Rising rates of digestive disorders and allergies in youngster's fuel demand for such customised remedies. Manufacturers are also developing appealing flavours and child-friendly formats, like gummies and powders, to encourage consumption. This focus on children aligns with broader health trends, boosting the segment's market growth.
Asia Pacific is expected to hold the largest market share during the forecast period due to the benefits of combining probiotics and prebiotics. Rising health consciousness, coupled with the growing prevalence of gastrointestinal disorders, has boosted demand for functional foods and dietary supplements. Countries like China, Japan, and India are at the forefront, with expanding product portfolios targeting diverse age groups. The integration of synbiotics into dairy products, beverages, and infant nutrition is particularly prominent. Moreover, innovation in formulation and increasing investments in research and development by key players further fuel market expansion.
North America is expected to have the highest CAGR over the forecast period, owing to increased consumer awareness of gut health and the benefits of combining probiotics and prebiotics. Rising demand for functional foods and dietary supplements, coupled with a focus on preventive healthcare, fuels the market's expansion. The region's robust food and beverage industry and advancements in biotechnology further support product innovation and availability. Key applications include dairy products, infant formula, and nutraceuticals. Major players are investing in R&D and strategic partnerships to meet evolving consumer preferences, ensuring steady growth in this health-conscious market.
Key players in the market
Some of the key players profiled in the Synbiotic Products Market include Seed Health, Inc., Sabinsa Corporation, Biomin America Inc., Probiotical S.p.A., Chobani Global Holdings LLC, United Natural Foods, Herbalife Nutrition Ltd., Yakult Honsha Co., Inc., Pfizer Inc., Daflorn Ltd., Danone S.A., HUM Nutrition, Aspera BY NU3X, Synbiotic Health and Chr. Hansen Holding A/S.
In October 2024, Sabinsa Corporation announced a multinational distribution agreement with Postbiotics, Inc. This agreement covers significant markets including the U.S., Canada, the European Union, India, and Japan. The partnership aims to distribute PoZibio, a dietary supplement and functional food ingredient that focuses on health benefits associated with postbiotics.
In September 2024, Seed Health partnered with Target to distribute its products in all Target stores and on Target's website. This partnership marks Seed Health's first collaboration with a major retailer, aiming to broaden access to its microbiome-directed innovations.
In May 2024, Seed Health launched VS-01(TM) Vaginal Synbiotic, the first clinically validated vaginal synbiotic designed to rapidly establish an optimal vaginal microbiome dominated by Lactobacillus crispatus. This product aims to redefine vaginal care by restoring the vagina's protective bacteria.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.